Table 2.
Outcomes of included studies
| Author (year) | Mean Age ± SD (Cirrhosis) | Mean Age (without Cirrhosis) | Mortality, n (%) Cirrhosis vs without Cirrhosis |
LOS ± SD (days) Cirrhosis vs without Cirrhosis |
Complications, n (%) | p value | OR (95% CI) |
|---|---|---|---|---|---|---|---|
| Al-Azzawi et al. (2018) | 46.68 | 43.75 (p = 0.54) |
In-patient 2 (0.5) vs 1 (0.3) (p = .56, OR = 2, 95% CI: 0.18–22.3) |
1.52 vs 1.1 (no SD) | Cirrhosis versus No Cirrhosis | ||
| Pneumonia 8 (2.1) vs 3 (0.8) | .142 | 2.72 (0.71–10.32) | |||||
| SSI 3 (0.8) vs 2 (0.5) | .652 | 1.52 (0.25–9.10) | |||||
| UTI 18 (4.8) vs 12 (3.2) | .26 | 1.53 (0.72–3.22) | |||||
| Wound bleeding 3 (0.8) vs 2 (0.5) | .65 | 1.51 (0.25–9.1) | |||||
| PE 1 (0.3) vs 0 | .94 | 0 (0.03–0.8) | |||||
| C. diff 1 (0.3) vs 0 | .99 | 0 (0.0–0.0) | |||||
| UGIB 3 (0.8) vs 1 (0.3) | .332 | 3.02 (0.3–29) | |||||
| Garcia et al. (2019) |
CC 56 ± 13 DC 55 ± 13 (Not significant) |
NC 44 ± 18 (p < 0.05 NC vs CC and NC vs DC) |
In-patient CC 5 (1.6) vs DC 9 (6.7) vs 458 (0.4) (p < 0.05 All pairs) |
Overall CC 7.1 ± 15.9 vs DC 9.5 ± 10.5 vs 3.4 ± 4.7 (p < 0.05 NC vs CC and NC vs DC) |
NOM vs OA vs LA No Cirrhosis |
||
| SSI N/a vs 227 (1.8) vs 558 (0.7) | < 0.05 | ||||||
| VTE 168 (1.4) vs 70 (0.6) vs 149 (0.2) | < 0.05 All pairs | ||||||
| UTI 752 (6.4) vs 475 (3.8) vs 2270 (2.7%) | < 0.05 All pairs | ||||||
| Compensated Cirrhosis | |||||||
| SSI N/a vs 4 (12.9) vs 4 (2.1) | < 0.05 | ||||||
| VTE 1 (1.2) vs 0 (0) vs 1 (0.5%) | Not significant | ||||||
| UTI 12 (14.8) vs 5 (16.1) vs 10 (5.2) | < 0.05 NOM vs LA | ||||||
| Decompensated Cirrhosis | |||||||
| SSI N/a vs 5 (20.8) vs 1 (2.1) | < 0.05 | ||||||
| VTE 1 (1.6) vs 1 (4.2) vs 1 (2.1) | Not significant | ||||||
| UTI 1 (1.6) vs 4 (16.7) vs 6 (12.8) | Not significant | ||||||
| Poulsen et al. (2000) | Not reported | Not reported |
30-day 6 (9) vs 413 (0.7) Adjusted OR (age, sex, co-morbidity) = 8 (95% CI 3–20) |
Not reported | Not reported | ||
| Tsugawa et al. (2001) |
OA 59.5 ± 11.5 LA 61.5 ± 8.5 (Not significant) |
N/a | OA 0 vs LA 0 | Cirrhotic OA 14.5 ± 4.3 vs Cirrhotic LA 8.2 ± 2.6) (p < 0.05) | Cirrhotic OA vs Cirrhotic LA | ||
| SSI 5 (20) vs 0 | < 0.05 | ||||||
| Wound bleeding 5 (20) vs 0 | < 0.05 | ||||||
| UTI 1 (4) vs 1 (6.7) | Not significant | ||||||
CC Compensated cirrhosis; DC Decompensated cirrhosis; NC No cirrhosis; OA Open appendicectomy; LA Laparoscopic appendicectomy; NOM Non-Operative management; SSI Surgical site infection; UTI Urinary tract infection; PE Pulmonary embolus; VTE Venous thromboembolism; C. diff, Clostridium difficile infection; UGIB Upper gastro-intestinal bleed; OR Odds ratio; CI Confidence interval